Practical Considerations for the Initiation and Maintenance of Etanercept in the Treatment of Psoriasis-Reference-Cited by-同舟云学术

Practical Considerations for the Initiation and Maintenance of Etanercept in the Treatment of Psoriasis

Published:2007-03 Issue:2_suppl Volume:11 Page:S37-S47
ISSN:1203-4754
Container-title:Journal of Cutaneous Medicine and Surgery
language:en
Short-container-title:J Cutan Med Surg

Author:

Guenther Lyn¹,Lynde Charles¹,Ho Vincent¹

Affiliation:

1. From the Division of Dermatology, University of Western Ontario, London, ON; The Guenther Dermatology Research Centre, London, ON; University Health Network, University of Toronto, Toronto, ON; Lynde Centre for Dermatology, Markham, ON; and Department of Dermatology, University of British Columbia, Vancouver, BC

Abstract

Etanercept is a new treatment for moderate to severe psoriasis. In contrast to traditional systemic agents, which can be given orally, etanercept is given by subcutaneous injection. Patient selection, transitioning, dosing, safety, monitoring, duration of therapy, and patient support programs are reviewed.

Publisher

SAGE Publications

Subject

Dermatology,Surgery

Link

http://journals.sagepub.com/doi/pdf/10.2310/7750.2006.00072

Reference39 articles.

1. Integrating Biologic Agents into Management of Moderate-to-Severe Psoriasis: A Consensus of the Canadian Psoriasis Expert Panel

2. Two considerations for patients with psoriasis and their clinicians:

3. AAD consensus statement on psoriasis therapies

4. Biological therapies in the systemic management of psoriasis: International Consensus Conference

5. A clinician's paradigm in the treatment of psoriasis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologic Therapy in Psoriasis: Perspectives on Associated Risks and Patient Management;Journal of Cutaneous Medicine and Surgery;2012-05